Issue Brief: Coverage for Evidence Development: A Conceptual Framework

Is there an alternative to a straightforward “yes” or “no” coverage decision by payers when the risks and benefits of an emerging technology1 remain unanswered? One alternative of interest to both U.S. and international payers is “Coverage for Evidence Development” (CED), which conditions coverage and payment for a technology on the collection of additional clinical evidence.

20090108 - CMTP - CED Issue Brief.pdf — PDF document, 171Kb